BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//KESHO - ECPv6.16.4.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://kesho-kenya.org
X-WR-CALDESC:Events for KESHO
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Africa/Nairobi
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0300
TZNAME:EAT
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20260305T190000
DTEND;TZID=Africa/Nairobi:20260305T203000
DTSTAMP:20260303T083141Z
CREATED:20260303T081324Z
LAST-MODIFIED:20260303T083141Z
UID:41277-1772737200-1772742600@kesho-kenya.org
SUMMARY:Women in Oncology
DESCRIPTION:[vc_row][vc_column][vc_column_text css=””] \nWomen in Oncology this International Women’s Day! \nJoin us for a powerful CPD Accredited webinar hosted by KESHO — Kenya Society of Haematology & Oncology \nDate: 5th March 2026 \nTime: 7:00 PM – 8:30 PM EAT \nModerator: \n\nDr. Gladwell Kiarie — Medical Oncologist\, The Nairobi Hospital\n\nSpeakers: \n\nProf. Verna Vanderpuye\n\nSenior Consultant Clinical Oncologist & Deputy Director\, National Centre of Radiotherapy\, Oncology and Nuclear Medicine\, Korle-bu Teaching Hospital\, Accra\, Ghana Topic: Legacy and Leadership: Mentorship from Women Advancing Oncology in Africa \n\nDr. Chemtai Mungo\n\nAssistant Professor of Obstetrics and Gynaecology & Physician-Scientist\, University of North Carolina at Chapel Hill Topic: Purpose-Driven Careers: Global Health\, Research and Women’s Impact in Oncology \n\nDr. Anne Mwirigi\n\nConsultant Haematologist and Assistant Professor\, Aga Khan University Hospital Topic: Growing in Specialised Oncology: Lessons in Haematology \n\nProf. Nazik Hammad\n\nProfessor of Medical Oncology\, Saint Michael’s Hospital and University of Toronto Topic: Building Impactful Careers in Global Oncology: Mentorship\, Leadership and Equity in Cancer Care[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_btn title=”CLICK TO REGISTER” color=”danger” css=”” link=”url:https%3A%2F%2Fus02web.zoom.us%2Fwebinar%2Fregister%2FWN_2lIM-Q1-Rm6JSxlo9b0jmQ”][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/women-in-oncology-2/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2026/03/WhatsApp-Image-2026-03-03-at-8.06.46-AM-e1772525890478.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20260226T190000
DTEND;TZID=Africa/Nairobi:20260226T203000
DTSTAMP:20260319T173215Z
CREATED:20260223T194335Z
LAST-MODIFIED:20260319T173215Z
UID:41036-1772132400-1772137800@kesho-kenya.org
SUMMARY:Precision Pathways in Lymphoma
DESCRIPTION:[vc_row][vc_column][vc_column_text css=””] \nDate: 26th February 2026Time: 7:00 PM – 8:30 PM (EAT) \n\nSpeakers \nModeratorDr Anne MwirigiConsultant Haematologist & Assistant Professor\, AKUH \nDr Rohini RadiaConsultant in BMT and Haematology\, Nairobi West HospitalStrategic Alignment in Lymphoma: From Precise Diagnosis to Clinical Excellence \nDr Jonathan WawireConsultant Anatomic Pathologist & Assistant Professor\, AKUHLymphoma Diagnostic Algorithm in Routine Practice \nHighlights\nThis session explored how lymphoma care is increasingly shaped by the alignment between diagnostic precision and therapeutic decision-making\, particularly in settings where access to advanced diagnostics remains variable. \nA central theme was the shift from morphology-led classification alone to a multi-parameter diagnostic approach\, integrating clinical context\, histopathology\, immunophenotyping and where available\, molecular profiling. As emphasized during the discussion\, classification is no longer purely descriptive: it directly determines treatment pathways\, prognosis and eligibility for emerging therapies. \nDr. Wawire outlined a structured diagnostic framework anchored on architecture\, cytology and clonality\, with morphology guiding the initial pathway and targeted immunohistochemistry refining classification. In routine practice\, a focused IHC panel (CD20\, CD3\, CD5\, CD10\, Cyclin D1) remains sufficient to classify most lymphomas and support timely clinical decisions. \nImportantly\, the session addressed the practical realities of diagnostic limitations. The distinction between “Not Otherwise Specified (NOS)” and “Not Further Classified (NFC)” was highlighted as a clinically responsible approach where molecular testing is unavailable maintaining transparency while ensuring patients are still appropriately managed. \nBuilding on this\, Dr. Radia emphasized that improved outcomes depend on early alignment between diagnostics\, treatment selection and delivery systems. In practice\, delays in diagnostic workflows or limited access to molecular testing can directly influence treatment choices and patient outcomes making coordination across pathology\, oncology and imaging essential. \nAs treatment options expand\, from immunochemotherapy to targeted agents\, CAR-T therapies and bispecific antibodies\, the need for early risk stratification and timely decision-making becomes even more critical\, particularly in balancing efficacy\, cost and access within real-world settings. \nAcross the case discussions\, a consistent message emerged: the quality and timeliness of diagnosis remain central to achieving better outcomes in lymphoma care. \nKey takeaways: \n\nLymphoma classification now relies on integrated clinical\, morphological and molecular assessment.\nFocused IHC panels remain highly effective in routine and resource-limited settings.\n“NFC” supports safe\, transparent reporting when advanced testing is unavailable.\nDiagnostic delays and access gaps can directly impact treatment decisions.\nEarly alignment across disciplines is essential to optimize outcomes.
URL:https://kesho-kenya.org/event/precision-pathways-in-lymphoma/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2026/02/WhatsApp-Image-2026-02-23-at-10.02.59-PM-e1771875762948.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20260219T190000
DTEND;TZID=Africa/Nairobi:20260219T203000
DTSTAMP:20260407T102753Z
CREATED:20260218T181534Z
LAST-MODIFIED:20260407T102753Z
UID:40973-1771527600-1771533000@kesho-kenya.org
SUMMARY:Management of Biliary and Gall Bladder Tumours
DESCRIPTION:SUMMARY \nAdvances in the Multidisciplinary Management of Biliary and Gallbladder Tumours \nSpeakers: Prof. Elly Ogutu\, Dr. Mohan Ramchandani\, Dr. Kausik Bhattacharya\, Dr. M. Vamshi Krishna \nDate: 19 February 2026 \nThis session examined the management of biliary and gallbladder tumours through a multidisciplinary lens\, highlighting the importance of coordinated approaches across endoscopy\, surgery and oncology in improving patient outcomes. \nA central theme was the role of accurate and timely diagnosis\, with particular emphasis on tissue acquisition and the contribution of advanced endoscopic techniques in guiding clinical decision-making. The discussion underscored how delays or limitations in diagnostic pathways can significantly influence treatment options and outcomes. \nThrough the KNH–UoN strategic training partnership and collaboration with the Asian Institute of Gastroenterology\, the session reflected the value of regional expertise and diaspora engagement in strengthening clinical capacity and expanding access to specialised skills. \nFrom a clinical perspective\, evolving therapeutic strategies—including advances in surgical techniques and radiation oncology—were highlighted as critical components of care\, particularly when integrated within a multidisciplinary framework that supports individualized treatment planning. \nAcross the session\, a consistent message emerged: improving outcomes in biliary and gallbladder cancers will depend on strengthening diagnostic pathways and ensuring coordinated\, multidisciplinary care across the patient journey. \nKey Takeaways \n\nEarly and accurate diagnosis remains central to effective management.\nAdvanced endoscopic techniques play a key role in tissue sampling and staging.\nMultidisciplinary coordination improves treatment planning and outcomes.\nRegional and diaspora collaboration strengthens clinical capacity.\nIntegration of surgical\, endoscopic and oncological care is essential.
URL:https://kesho-kenya.org/event/management-of-biliary-and-gall-bladder-tumours/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2026/02/WhatsApp-Image-2026-02-18-at-10.47.07-AM-e1771438592764.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20260212T080000
DTEND;TZID=Africa/Nairobi:20260212T170000
DTSTAMP:20260407T085208Z
CREATED:20251222T170033Z
LAST-MODIFIED:20260407T085208Z
UID:40759-1770883200-1770915600@kesho-kenya.org
SUMMARY:Environmental Risks of Cancer
DESCRIPTION:Speakers: Dr. Mary Nyangasi\, Dr. David Githanga\, Dr. Carolina Espina\nDate: 12 February 2026 \nHighlights\nThis session examined cancer risk through an environmental and public health lens\, highlighting the extent to which cancer burden is shaped by modifiable exposures rather than biology alone. A central theme was the recognition that cancer is not only a clinical or genetic condition\, but also a social and environmental disease\, with a substantial proportion of cases linked to preventable risk factors. Global evidence suggests that up to 40% of cancers are attributable to modified exposures\, including environmental and occupational risks. Dr. Githanga outlined the biological mechanisms through which environmental exposures drive carcinogenesis\, including DNA damage\, chronic inflammation\, epigenetic dysregulation and impaired immune surveillance. These pathways act cumulatively over time\, often with long latency periods between exposure and disease manifestation. \nReal-world examples such as air pollution\, aflatoxin exposure and oncogenic infections illustrate how environmental context directly shapes cancer patterns\, particularly in low- and middle-income settings where exposure levels are higher and regulatory systems less robust. Building on this\, Dr. Nyangasi emphasized that a significant proportion of cancer burden is preventable\, with WHO frameworks highlighting the importance of population-level interventions targeting modifiable risk factors\, including environmental regulation\, vaccination and lifestyle-related risks. \nDr. Espina introduced the World Code Against Cancer framework\, which translates complex scientific evidence into clear\, actionable recommendations for individuals\, health systems and policymakers. The framework underscores the importance of moving beyond individual behavior change towards coordinated\, multi-sectoral prevention strategies. Across the session\, a consistent message emerged: meaningful reductions in cancer burden will depend on shifting upstream towards prevention\, regulation and system-level action \nKey Takeaways  \n\nA substantial proportion of cancers are linked to modifiable environmental and behavioral exposures.\nEnvironmental carcinogenesis occurs through multi-pathway biological mechanisms over time.\nExposure to risk is uneven and shaped by social and economic conditions.\nPopulation-level interventions have greater impact than individual behavior change alone.\nEffective cancer control requires alignment between clinical practice\, public health and policy.
URL:https://kesho-kenya.org/event/environmental-risks-of-cancer/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/png:https://kesho-kenya.org/wp-content/uploads/2025/12/Environmental-Risks-of-Cancer.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20260205T190000
DTEND;TZID=Africa/Nairobi:20260205T203000
DTSTAMP:20260319T172224Z
CREATED:20260203T112643Z
LAST-MODIFIED:20260319T172224Z
UID:40841-1770318000-1770323400@kesho-kenya.org
SUMMARY:World Cancer Day
DESCRIPTION:[vc_row][vc_column][vc_column_text] \nWorld Cancer Day: \nUnited by Unique – The Kenyan Perspective \nDate: 5th February 2025Time: 7:00 PM – 8:30 PM (EAT) \nModerator \nDr. Gladwell KiarieMedical Oncologist\, The Nairobi Hospital \nSpeakers \nHon. Dr. Ouma OlugaPrincipal Secretary for the State Department for Medical Services\,Ministry of Health\, Kenya \nHon. Dr. James NyikalChairperson of the National Assembly Departmental Committee on Health\, Kenya \nDr. Mercy MwangangiChief Executive Officer\, Social Health Authority \nDr. Elias MellyChief Executive Officer\, National Cancer Institute\, Kenya \nDr. Ahmed OgwellPublic Health Expert\, CEO & President\, VillageReach \nPrisca GithukaVice-Chairperson & Advocacy Chair\,Kenyan Network of Cancer Organizations (KENCO) and Chairlady\,Cancer Survivors Association of Kenya \nHighlights\nThis session brought together clinical\, policy and advocacy voices to reflect on the current state of cancer care in Kenya\, with a focus on how systems\, leadership and lived experience intersect to shape outcomes. \nA central theme was the need to move beyond fragmented approaches towards coordinated\, patient-centered cancer control\, grounded in national priorities and responsive to the realities of care delivery. The discussion highlighted that improving outcomes requires not only clinical excellence\, but also alignment across policy\, financing and implementation. \nSpeakers emphasized the importance of strengthening health systems to support prevention\, early detection and access to treatment\, while addressing structural barriers that continue to limit equitable care. The role of national institutions\, policy frameworks and cross-sector collaboration emerged as critical in driving sustainable progress. \nPatient voice and lived experience were also highlighted as essential to shaping responsive and inclusive cancer care strategies\, ensuring that interventions reflect the needs and realities of those most affected. \nAcross the discussion\, a consistent message emerged: meaningful progress in cancer control will depend on alignment between policy\, practice and people. \nKey Takeaways \n\nEffective cancer control requires alignment across clinical care\, policy and implementation.\nStrengthening health systems is essential to improving access\, equity and outcomes.\nPrevention and early detection remain critical entry points for reducing burden.\nPatient voice and lived experience are key to responsive\, person-centered care.\nSustainable progress depends on multi-sector collaboration and leadership.\n\nWatch the full session here: \n    	\n        Watch Video
URL:https://kesho-kenya.org/event/world-cancer-day/
LOCATION:Virtual Event (Zoom)\, Kenya
CATEGORIES:CME 2026,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2026/02/WhatsApp-Image-2026-02-03-at-2.30.14-PM-e1770118388259.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20260131T080000
DTEND;TZID=Africa/Nairobi:20260131T170000
DTSTAMP:20251223T153057Z
CREATED:20251222T165602Z
LAST-MODIFIED:20251223T153057Z
UID:40755-1769846400-1769878800@kesho-kenya.org
SUMMARY:HPV Vaccine  Campaign/Outreach Screening
DESCRIPTION:
URL:https://kesho-kenya.org/event/hpv-vaccine-campaign-outreach-screening/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20260122T190000
DTEND;TZID=Africa/Nairobi:20260122T203000
DTSTAMP:20260319T171500Z
CREATED:20251222T165215Z
LAST-MODIFIED:20260319T171500Z
UID:40753-1769108400-1769113800@kesho-kenya.org
SUMMARY:Cervical Cancer Prevention and Control In Kenya
DESCRIPTION:[vc_row][vc_column][vc_column_text css=””] \n(CPD Accredited) \nDate & Time: 22nd January 2026 7 PM – 8:30 PM (EAT) \n\nModerator: Dr. Benjamin Elly Odongo\nObstetrician/Gynecologist & Gynaecologic Oncologist\, Senior Lecturer & Chairman\, Department of Obstetrics & Gynaecology\, Kenyatta University School of Health Sciences\n\nSpeakers: \nProf. Lucy Muchiri\nAssociate Professor in the Department of Human Pathology\, University of Nairobi’s School of Medicine\nTopic: Overview of the WHO 90-70-90 cervical cancer elimination strategy and implications for pathology services \nProf. Omu Anzala Professor of Virology and Immunology\, Department of Medical Microbiology; Senior Research Scientist at KAVI – Institute of Clinical Research (KAVI – ICR)\, University of Nairobi\, Kenya\nTopic: HPV Vaccination in Kenya: Scientific Evidence\, Immunological Perspectives\, and Public Controversies \nDr. Richa Bansal Gynecological Oncologist and Robotic Surgeon\, Apollo Hospitals\, Navi Mumbai\, India\nTopic: Cervical Cancer Prevention and Advanced Treatment \nHighlights\nThis session examined cervical cancer through the lens of prevention\, highlighting it as one of the few cancers where elimination is both feasible and within reach. \nA central theme was the WHO 90-70-90 strategy\, which outlines a clear pathway to elimination through HPV vaccination\, screening and timely treatment. Achieving these targets could reduce cervical cancer incidence to below 4 cases per 100\,000 women\, effectively transforming it into a rare disease. \nThe discussion emphasized that cervical cancer is almost entirely driven by persistent HPV infection\, making it uniquely preventable through vaccination and early detection. Evidence shows that HPV vaccines are highly effective\, with strong and sustained protection against high-risk HPV types responsible for most cases. \nDespite this\, the burden remains disproportionately high in low- and middle-income settings\, including Kenya\, where gaps in screening coverage\, diagnostic capacity and referral pathways continue to limit early detection and timely treatment. \nThe role of pathology services emerged as critical\, forming the diagnostic backbone for screening programs and treatment decisions. Expanding HPV DNA testing\, strengthening laboratory systems and investing in workforce development were identified as key priorities for achieving national targets. \nAcross the session\, a consistent message emerged: cervical cancer is preventable and eliminating it will depend on scaling what already works. \nKey Takeaways \n\nCervical cancer is one of the few cancers where elimination is achievable.\nThe WHO 90-70-90 targets provide a clear\, evidence-based roadmap.\nHPV vaccination and screening are high-impact prevention strategies.\nStrengthening pathology and diagnostic capacity is essential to progress.\nClosing gaps in access and coverage is critical to achieving equitable outcomes.
URL:https://kesho-kenya.org/event/cervical-cancer-prevention/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2026/01/WhatsApp-Image-2026-01-20-at-9.44.15-AM-e1768910604384.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20251222T080000
DTEND;TZID=Africa/Nairobi:20251222T170000
DTSTAMP:20251223T152917Z
CREATED:20251222T171421Z
LAST-MODIFIED:20251223T152917Z
UID:40765-1766390400-1766422800@kesho-kenya.org
SUMMARY:Multiple Myeloma
DESCRIPTION:
URL:https://kesho-kenya.org/event/multiple-myeloma-2/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250625T190000
DTEND;TZID=Africa/Nairobi:20250625T203000
DTSTAMP:20251223T210004Z
CREATED:20251223T210004Z
LAST-MODIFIED:20251223T210004Z
UID:40823-1750878000-1750883400@kesho-kenya.org
SUMMARY:Sickle Cell Disease
DESCRIPTION:
URL:https://kesho-kenya.org/event/sickle-cell-disease-3/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250618T190000
DTEND;TZID=Africa/Nairobi:20250618T203000
DTSTAMP:20251223T205914Z
CREATED:20251223T205914Z
LAST-MODIFIED:20251223T205914Z
UID:40821-1750273200-1750278600@kesho-kenya.org
SUMMARY:Cancer and Nutrition
DESCRIPTION:
URL:https://kesho-kenya.org/event/cancer-and-nutrition/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250611T190000
DTEND;TZID=Africa/Nairobi:20250611T203000
DTSTAMP:20251223T205807Z
CREATED:20251223T205807Z
LAST-MODIFIED:20251223T205807Z
UID:40819-1749668400-1749673800@kesho-kenya.org
SUMMARY:Palliative Care: Integrative  Oncology
DESCRIPTION:
URL:https://kesho-kenya.org/event/palliative-care-integrative-oncology/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250604T190000
DTEND;TZID=Africa/Nairobi:20250604T203000
DTSTAMP:20251223T205705Z
CREATED:20251223T205510Z
LAST-MODIFIED:20251223T205705Z
UID:40817-1749063600-1749069000@kesho-kenya.org
SUMMARY:Cancer Survivorship
DESCRIPTION:
URL:https://kesho-kenya.org/event/cancer-survivorship/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250528T190000
DTEND;TZID=Africa/Nairobi:20250528T203000
DTSTAMP:20251223T205348Z
CREATED:20251223T205348Z
LAST-MODIFIED:20251223T205348Z
UID:40815-1748458800-1748464200@kesho-kenya.org
SUMMARY:Brain Cancer / Brain Tumour
DESCRIPTION:
URL:https://kesho-kenya.org/event/brain-cancer-brain-tumour/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250514T190000
DTEND;TZID=Africa/Nairobi:20250514T203000
DTSTAMP:20251223T205123Z
CREATED:20251223T205123Z
LAST-MODIFIED:20251223T205123Z
UID:40811-1747249200-1747254600@kesho-kenya.org
SUMMARY:Melanoma/Skin Cancer
DESCRIPTION:
URL:https://kesho-kenya.org/event/melanoma-skin-cancer/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250430T190000
DTEND;TZID=Africa/Nairobi:20250430T203000
DTSTAMP:20251223T204854Z
CREATED:20251223T204854Z
LAST-MODIFIED:20251223T204854Z
UID:40807-1746039600-1746045000@kesho-kenya.org
SUMMARY:Testicular Cancer
DESCRIPTION:
URL:https://kesho-kenya.org/event/testicular-cancer-2/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250423T190000
DTEND;TZID=Africa/Nairobi:20250423T203000
DTSTAMP:20251223T204641Z
CREATED:20251223T204641Z
LAST-MODIFIED:20251223T204641Z
UID:40805-1745434800-1745440200@kesho-kenya.org
SUMMARY:World AML Day (21st)
DESCRIPTION:
URL:https://kesho-kenya.org/event/world-aml-day-21st/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250421T190000
DTEND;TZID=Africa/Nairobi:20250421T203000
DTSTAMP:20251223T210251Z
CREATED:20251223T205238Z
LAST-MODIFIED:20251223T210251Z
UID:40813-1745262000-1745267400@kesho-kenya.org
SUMMARY:Bladder Cancer
DESCRIPTION:
URL:https://kesho-kenya.org/event/bladder-cancer-2/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250416T190000
DTEND;TZID=Africa/Nairobi:20250416T203000
DTSTAMP:20251223T204430Z
CREATED:20251223T204430Z
LAST-MODIFIED:20251223T204430Z
UID:40803-1744830000-1744835400@kesho-kenya.org
SUMMARY:Head & Neck Cancer
DESCRIPTION:
URL:https://kesho-kenya.org/event/head-neck-cancer/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250409T190000
DTEND;TZID=Africa/Nairobi:20250409T203000
DTSTAMP:20251223T204319Z
CREATED:20251223T204319Z
LAST-MODIFIED:20251223T204319Z
UID:40801-1744225200-1744230600@kesho-kenya.org
SUMMARY:Esophageal Cancer
DESCRIPTION:
URL:https://kesho-kenya.org/event/esophageal-cancer-3/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250402T190000
DTEND;TZID=Africa/Nairobi:20250402T203000
DTSTAMP:20251223T204154Z
CREATED:20251223T204154Z
LAST-MODIFIED:20251223T204154Z
UID:40798-1743620400-1743625800@kesho-kenya.org
SUMMARY:Bowel Cancer
DESCRIPTION:
URL:https://kesho-kenya.org/event/bowel-cancer/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250326T190000
DTEND;TZID=Africa/Nairobi:20250326T203000
DTSTAMP:20251223T152905Z
CREATED:20251222T172322Z
LAST-MODIFIED:20251223T152905Z
UID:40769-1743015600-1743021000@kesho-kenya.org
SUMMARY:International Women’s Day Women in Oncology
DESCRIPTION:
URL:https://kesho-kenya.org/event/international-womens-day-women-in-oncology/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250326T190000
DTEND;TZID=Africa/Nairobi:20250326T203000
DTSTAMP:20251223T210322Z
CREATED:20251223T204036Z
LAST-MODIFIED:20251223T210322Z
UID:40796-1743015600-1743021000@kesho-kenya.org
SUMMARY:Colorectal Cancer
DESCRIPTION:
URL:https://kesho-kenya.org/event/colorectal-cancer-2/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250313T190000
DTEND;TZID=Africa/Nairobi:20250314T203000
DTSTAMP:20251223T152912Z
CREATED:20251222T171550Z
LAST-MODIFIED:20251223T152912Z
UID:40767-1741892400-1741984200@kesho-kenya.org
SUMMARY:WoCa Summit EA
DESCRIPTION:
URL:https://kesho-kenya.org/event/woca-summit-ea/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250305T190000
DTEND;TZID=Africa/Nairobi:20250305T203000
DTSTAMP:20251223T152927Z
CREATED:20251222T171137Z
LAST-MODIFIED:20251223T152927Z
UID:40763-1741201200-1741206600@kesho-kenya.org
SUMMARY:Kidney Cancer
DESCRIPTION:
URL:https://kesho-kenya.org/event/kidney-cancer-2/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250219T190000
DTEND;TZID=Africa/Nairobi:20250219T203000
DTSTAMP:20251223T152934Z
CREATED:20251222T170110Z
LAST-MODIFIED:20251223T152934Z
UID:40761-1739991600-1739997000@kesho-kenya.org
SUMMARY:Gallbladder & Bile Duct Cancer  Awareness
DESCRIPTION:
URL:https://kesho-kenya.org/event/gallbladder-bile-duct-cancer-awareness/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250205T190000
DTEND;TZID=Africa/Nairobi:20250205T203000
DTSTAMP:20251223T153047Z
CREATED:20251222T165950Z
LAST-MODIFIED:20251223T153047Z
UID:40757-1738782000-1738787400@kesho-kenya.org
SUMMARY:World Cancer Day   Building a Resilient Oncology  Workforce: Addressing Capacity  Gaps in Cancer Management in  Kenya
DESCRIPTION:
URL:https://kesho-kenya.org/event/world-cancer-day-building-a-resilient-oncology-workforce-addressing-capacity-gaps-in-cancer-management-in-kenya/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
END:VEVENT
END:VCALENDAR